Institutional Ownership
Sarepta Therapeutics Inc
CUSIP 803607100COMSRPTQ1 2026
13D / 13G Filings
37
Schedule 13D/13G on record
Beneficial Filers
13
Distinct reporting persons
Largest Stake
12.6%
Max % of class reported
Institutional Holders
330
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
37 filings · latest Feb 13, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2026 | Aqr Capital Management, LLC | 13G | 7.7% | 81.05T | SEC |
| 2 | Jan 21, 2026 | Blackrock, Inc. | 13G/A | 12.6% | 13.23M | SEC |
| 3 | Nov 14, 2025 | D. E. Shaw &Amp; Co., L.P. | 13G/A | 1.9% | 2.01M | SEC |
| 4 | Nov 10, 2025 | State Street Corporation | 13G | 5.4% | 5.30M | SEC |
| 5 | Sep 8, 2025 | The Vanguard Group | 13G/A | 10.9% | 10.64M | SEC |
| 6 | Aug 13, 2025 | Capital International Investors | 13G/A | 0.5% | 524.1K | SEC |
| 7 | Jul 25, 2025 | D. E. Shaw &Amp; Co., L.P. | 13G/A | 5.1% | 5.06M | SEC |
| 8 | Jul 25, 2025 | D. E. Shaw &Amp; Co., L.P. | 13G | 5.1% | 5.06M | SEC |
| 9 | Feb 14, 2025 | Capital International Investors | 13G/A | 9.3% | 8.90M | SEC |
| 10 | Nov 14, 2024 | Janus Henderson Group PLC | 13G/A | 4.6% | 4.36M | SEC |
27 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Sarepta Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 14.76M | $321.07M |
| 2 | State Street Corp | 6.61M | $143.91M |
| 3 | Aqr Capital Management LLC | 6.43M | $138.63M |
| 4 | Two Sigma Investments, LP | 4.59M | $99.95M |
| 5 | First Trust Advisors LP | 4.14M | $89.99M |
| 6 | Ra Capital Management, L.P. | 3.90M | $84.92M |
| 7 | Erste Asset Management Gmbh | 2.97M | $61.29M |
| 8 | Morgan Stanley | 2.60M | $56.51M |
| 9 | Aberdeen Group PLC | 2.32M | $50.46M |
| 10 | Ubs Group AG | 2.23M | $48.58M |